Stage D1 (T1-3, N1-3, M0) prostate cancer: A case-controlled comparison of conservative treatment versus radical prostatectomy

Urology

Volumn 50, Issue 2, 1997, Pages 251-255

  Cadeddu, Jeffrey A ^a,b   Partin, Alan W ^a   Epstein, Jonathan I ^a   Walsh, Patrick C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; CASE-CONTROL STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0030835733     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00186-6     Document Type: Article

References (16)

1. Zincke H, Utz DC, Thule PM, and Taylor WF: Treatment options for patients with stage D1 (T0-3, N1-2, M0) adenocarcinoma of prostate. Urology 30: 307-315, 1987.
2. Golimbu M, Provet J, Al-Askari S, and Morales P: Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment. Urology 30: 427-435, 1987.
3. Frazier HA, Robertson JE, and Paulson DF: Does radical prostatectomy in the presence of positive lymph nodes enhance survival? World J Urol 12: 308-312, 1994.
4. Frohmuller HGW, Theiss M, Manseck A, and Wirth MP: Survival and quality of life of patients with stage D1 (T1-3, pN1-2, M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone. Eur Urol 27: 202-206, 1995.
5. Cheng CWS, Bergstralh EJ, and Zincke H: Stage D1 prostate cancer. A non-randomized comparison of conservative treatment options versus radical prostatectomy. Cancer 71 (suppl 3): 996, 1993.
6. Steinberg GD, Epstein JI, Piantadosi S, and Walsh PC: Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144: 1425-1432, 1990.
7. Smith JA, and Middleton RG: Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J Urol 133: 617-619, 1985.
8. Schmidt JD, Gibbons RP, Bartolucci A, Murphy GP, et al, for the National Prostatic Cancer Treatment Group. Prognosis in stage D1 prostate cancer relative to anatomic sites of nodal metastases. Cancer 64: 1743-1746, 1989.
9. Walsh PC: Radical retropubic prostatectomy, in Walsh PC, Retik AB, Stamey TA, and Vaughan ED Jr (Eds): Campbell's Urology, 6th ed. Philadelphia, WB Saunders, 1986, vol 3, pp 2865-2886.
10. Steckel J, and deKernion JB: Therapeutic options for stage D1 prostate cancer, in Ball TP, Novicki DE, Montano G, Barrett DM, Devine CJ, Donohue JP, Duckett JW, Fair WR, Gibbons RP, Marshall FF, et al: (Eds): AUA Update Series, Bellaire, Texas, AUA Office of Education, 1994, vol 13, lesson 21, pp 166-171.
11. Sgrignoli AR, Walsh PC, Steinberg GD, Steiner MS, and Epstein JI: Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 152: 1077-1081, 1994.
12. deKernion JB, Huang MY, Kaufman JJ, and Smith RB: Result of treatment of patients with stage D1 prostatic carcinoma. Urology 26: 446-451, 1985.
13. Zincke H: Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. Urology 33: 27-36, 1989.
14. deKernion JB, Neuwirth H, Stein A, Dorey F, Stenzl A, Hannah J, and Blyth B: Prognosis of patients with stage D1 prostatic adenocarcinoma following radical prostatectomy with and without early endocrine therapy. J Urol 144: 700-703, 1990.
15. Brawn P, Kuhl D, Johnson C, Pandya P, and McCord R: Stage D1 prostate carcinoma. The histologic appearance of nodal metastases and its relationship to survival. Cancer 65: 538-543, 1990.
16. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, and Scardino PT: Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142: 332-336, 1989.